Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular dege (Q82665975)
Jump to navigation
Jump to search
scientific article published on 19 November 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular dege |
scientific article published on 19 November 2008 |
Statements
Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration (English)
M P Avila
M E Farah
A Santos
J P Duprat
B W Woodward
19 November 2008